Press Release | Fri Aug 9, 2013 2:00am EDT

Oral Anti-Cancer Therapy Pomalidomide Now Approved by European Commission as Treatment for Patients with Relapsed/Refractory Multiple Myeloma – a Rare Form of Blood Cancer

* Reuters is not responsible for the content in this press release.